•  Home
  • About Us
    • Management & Directors
    • Scientific Advisors
    • Investors
    • Career Opportunities
  •  Pipeline
    • Lead Product
  •    Nanotemplate Engineering®
    • Nanotechnology
    • Other Applications
  •  Films & Gels
    • Thin-Film Composties
    • Bioadhesive Berry Gel
    • Film-Forming Gels
  •  Publications
  • Latest News
    • Company News
    • In the News
  • Contact
  • Add Feed
  • Google Reader or Homepage
  • Add to My Yahoo!
  • Subscribe with Bloglines
  • Subscribe in NewsGator Online
  • Add to Technorati Favorites!
Subscribe via Email


NanoMed Releases

Chemopreventative effects of a topically applied black raspberry gel on oral premalignant tumors.

NanoMed Pharmaceuticals Founder Joins Faculty at UNC School of Pharmacy

NanoMed Pharmaceuticals Hires Chief Scientific Officer

Archives

Year 2007

Year 2006

Year 2005

Year 2004

Year 2003

Home » In the News » With Soaring R&D Costs and a Dearth of Blockbuster Drugs, Nanotechnology...

With Soaring R&D Costs and a Dearth of Blockbuster Drugs, Nanotechnology could yet Prove to be the Saviour of the Pharmaceutical Industry

(January 29, 2007) With Soaring R&D Costs and a Dearth of Blockbuster Drugs, Nanotechnology could yet Prove to be the Saviour of the Pharmaceutical Industry

 

 

Go Back to In the News
Company News
In the News


Home About Us Pipeline Nanotechnology Films & Gels Publications Latest News Contact Us Site Map Privacy Statement Terms of Use
Copyright © 2001-2007 NanoMed Pharmaceuticals®, Inc. All rights reserved.